Harrow, Inc. (HROW)

46.79 +2.23 (+5.00%) USD  |  NASDAQ  |  Dec 19, 11:25
More

Harrow Unrealized Gain (Loss) on Investment Securities (Quarterly)

Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart

View Unrealized Gain (Loss) on Investment Securities (Quarterly) for HROW.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Unrealized Gain (Loss) on Investment Securities (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks

View Unrealized Gain (Loss) on Investment Securities (Quarterly) Benchmarks
Start Trial
Assertio Holdings, Inc. --
Skye Bioscience, Inc. --
Theravance Biopharma, Inc. --
FibroGen, Inc. --
NovaBay Pharmaceuticals, Inc. --